What is the edge of Telmisartan over other ARBs in terms of anti-inflammatory effects for diabetic patients?

Document ID: PC-MY-102465

08/08/2022

Author: Boehringer Ingelheim

Related content

 
PC-MY-102465
Production date: August 2022